V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10006811 | 10004655 | 1.65 | 40.8 | Curative (C) | 2018-09-09 | 2018-10-19 | FLUOROURACIL + FOLINIC ACID | 02 | Y | 10466478 | LENALIDOMIDE |
| 10006812 | 10004658 | null | 61.2 | Palliative (P) | 2016-11-04 | 2016-11-04 | FLUOROURACIL + FOLINIC ACID | N | N | 10466552 | CARBOPLATIN |
| 10006813 | 10004659 | 1.79 | 85.7 | Palliative (P) | 2017-03-05 | 2017-03-18 | Abiraterone | 2 | N | 10466616 | CARBOPLATIN + VINORELBINE |
| 10006814 | 10007371 | 1.59 | 60 | Palliative (P) | 2018-06-04 | 2018-06-10 | Pemetrexed | 02 | N | 10466668 | CVP R |
| 10006815 | 10007371 | 1.75 | null | Palliative (P) | null | 2018-04-11 | Azacitidine | 02 | null | 10466668 | AZACITIDINE |
| 10006816 | 10004660 | 1.69 | 111 | Palliative (P) | 2015-12-20 | 2016-01-10 | GEMCARBO | null | N | 10467100 | CARBOPLATIN + PEMETREXED |
| 10006817 | 10004660 | 1.65 | 67.7 | Curative (C) | 2018-09-18 | 2018-09-18 | Pemetrexed | 2 | N | 10467100 | CARBOPLATIN + VINORELBINE |
| 10006818 | 10004661 | null | 85.2 | Palliative (P) | 2013-12-22 | 2014-01-19 | Azacitidine | N | N | 10467268 | AZACITIDINE |
| 10006819 | 10004667 | 1.63 | 82 | null | 2017-02-16 | 2017-02-18 | CARBOPLATIN | 2 | N | 10467415 | CARBOPLATIN + VINORELBINE |
| 10006820 | 10004667 | 1.7 | 70.2 | Curative (C) | null | 2017-08-16 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 10467415 | CARBOPLATIN + PACLITAXEL |
| 10006821 | 10004669 | 1.75 | 78.1 | Palliative (P) | 2015-02-20 | 2015-03-02 | BCG Intravesical | null | Y | 10467497 | IBRUTINIB |
| 10006822 | 10004672 | null | null | Curative (C) | 2014-02-01 | 2014-02-03 | BENDAMUSTINE + RITUXIMAB | Y | N | 10467641 | BENDAMUSTINE + RITUXIMAB |
| 10006823 | 10004674 | 1.66 | 81.4 | Palliative (P) | 2012-07-20 | 2013-04-09 | BCG Intravesical | N | N | 10467810 | CARBOPLATIN + PEMETREXED |
| 10006824 | 10004675 | 1.75 | 92.6 | Disease modification (D) | null | 2017-02-20 | LENALIDOMIDE | N | null | 10467913 | CVP R |
| 10006825 | 10004676 | 1.55 | 43 | Disease modification (D) | 2014-01-11 | 2014-01-16 | BENDAMUSTINE + RITUXIMAB | N | N | 10467992 | BENDAMUSTINE + RITUXIMAB |
| 10006826 | 10004678 | 1.69 | 60.9 | c | 2017-01-22 | 2017-01-29 | GEMCITABINE | N | N | 10468128 | FLUOROURACIL |
| 10006827 | 10004679 | 1.62 | 60.5 | Neo-adjuvant (N) | 2016-10-02 | 2016-10-02 | Carboplatin + Vinorelbine Oral | N | N | 10468128 | CARBOPLATIN |
| 10006828 | 10004679 | 0 | 92.7 | Curative (C) | 2017-04-02 | 2017-04-23 | Carboplatin + Pemetrexed | N | N | 10468128 | ABIRATERONE |
| 10006829 | 10004680 | 1.57 | 58.5 | Palliative (P) | 2016-12-31 | 2017-01-13 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | null | 10468337 | PEMETREXED |
| 10006830 | 10004681 | 1.79 | 109 | Palliative (P) | null | 2017-06-13 | BENDAMUSTINE + RITUXIMAB | 2 | null | 10468480 | BENDAMUSTINE + RITUXIMAB |
| 10006831 | 10004682 | null | 138 | Neo-adjuvant (N) | 2017-04-02 | 2017-04-03 | IBRUTINIB | 02 | N | 10468579 | CARBOPLATIN + PEMETREXED |
| 10006832 | 10004683 | 1.7 | 72 | Adjuvant (A) | 2017-12-03 | 2017-12-03 | Temozolomide 200mg/m2 | N | N | 10468775 | TEMOZOLOMIDE |
| 10006833 | 10004684 | null | null | Palliative (P) | 2018-07-17 | 2018-07-17 | Carboplatin + Etoposide IV 3 day | N | null | 10468787 | CARBOPLATIN + ETOPOSIDE |
| 10006834 | 10004684 | 1.49 | 60 | Palliative (P) | 2017-02-21 | 2017-02-21 | Carboplatin + Etoposide iv&po | 2 | N | 10468787 | CARBOPLATIN + ETOPOSIDE |
| 10006835 | 10004685 | null | 63.7 | Curative (C) | 2016-11-19 | 2016-11-20 | Trial Unspecified | null | null | 10469044 | TRIAL |
| 10006836 | 10004686 | 1.67 | 49 | Palliative (P) | 2016-09-18 | 2016-09-25 | Capecitabine | N | null | 10469222 | CAPECITABINE |
| 10006837 | 10004686 | 1.57 | 60.9 | Curative (C) | 2018-11-12 | 2018-11-12 | Trial Unspecified | N | N | 10469222 | TRIAL |
| 10006838 | 10004687 | 1.74 | 75 | Palliative (P) | 2018-11-26 | 2018-11-26 | CARBOPLATIN | 2 | N | 10469238 | BCG |
| 10006839 | 10007381 | 1.67 | 92 | Curative (C) | 2016-02-27 | 2016-06-21 | Carboplatin + Pemetrexed | 2 | N | 10469249 | BCG |
| 10006840 | 10004688 | 1.81 | 72 | Palliative (P) | 2015-10-11 | 2015-10-18 | Carboplatin + Etoposide iv&po | N | N | 10469298 | CARBOPLATIN + ETOPOSIDE |
| 10006841 | 10004689 | 1.85 | 84 | Palliative (P) | null | 2017-08-22 | Carboplatin + Etoposide iv&po | 02 | N | 10469325 | CARBOPLATIN + ETOPOSIDE |
| 10006842 | 10004689 | null | 69.5 | Disease modification (D) | 2016-03-26 | 2016-03-31 | BCG Intravesical | 2 | N | 10469325 | LENALIDOMIDE |
| 10006843 | 10004691 | 1.65 | 74 | Adjuvant (A) | 2016-10-01 | 2016-11-01 | IBRUTINIB | 02 | N | 10469418 | CARBOPLATIN + PEMETREXED |
| 10006844 | 10004693 | null | null | Palliative (P) | 2016-12-06 | 2017-01-06 | BCG Intravesical | 2 | N | 10469609 | BEVACIZUMAB |
| 10006845 | 10007384 | 1.69 | 91.9 | Neo-adjuvant (N) | 2014-01-26 | 2014-01-26 | CARBOPLATIN + FLUOROURACIL + Trastuzumab | N | N | 10469631 | CARBOPLATIN |
| 10006846 | 10007384 | 1.65 | null | Curative (C) | 2016-08-22 | 2016-11-19 | FLUOROURACIL + FOLINIC ACID | null | N | 10469631 | CARBOPLATIN |
| 10006847 | 10004694 | null | 60 | Curative (C) | 2018-10-30 | 2018-11-04 | Bevacizumab | 02 | Y | 10470282 | NOT MATCHED |
| 10006848 | 10004695 | 1.76 | 67.9 | Palliative (P) | 2018-06-22 | 2018-08-13 | Abiraterone | 02 | N | 10470305 | BCG |
| 10006849 | 10004698 | null | 83.1 | Disease modification (D) | 2018-01-31 | 2018-02-10 | BCG Intravesical | null | null | 10470857 | CARBOPLATIN + PEMETREXED |
| 10006850 | 10004700 | 1.65 | 68.8 | Palliative (P) | null | 2015-01-18 | Trial Unspecified | N | null | 10471054 | TRIAL |
| 10006851 | 10004702 | 1.75 | 72 | Curative (C) | 2016-09-30 | 2016-09-30 | Bevacizumab | 02 | N | 10471856 | LENALIDOMIDE |
| 10006852 | 10004705 | 1.57 | 69.8 | Palliative (P) | 2016-03-03 | 2016-03-30 | FEC | N | N | 10471931 | MITOMYCIN INTRAVESICULAR |
| 10006853 | 10004706 | 1.9 | 73 | Palliative (P) | 2017-08-19 | 2017-08-23 | Chlorambucil | N | N | 10472173 | FCR |
| 10006854 | 10004708 | 1.58 | 68.1 | Curative (C) | 2018-11-15 | 2018-12-02 | FLAIR Trial | 02 | N | 10472325 | RITUXIMAB + VINBLASTINE |
| 10006855 | 10004710 | 1.85 | null | Disease modification (D) | null | 2017-01-13 | EOX | 02 | N | 10472325 | CISPLATIN |
| 10006856 | 10004713 | 1.63 | null | Curative (C) | 2017-01-26 | 2017-01-29 | CHOP R + METHOTREXATE | N | N | 10472954 | MITOMYCIN INTRAVESICULAR |
| 10006857 | 10004713 | 1.87 | 96.9 | Curative (C) | 2018-05-17 | 2018-05-18 | Melphalan IV High dose | N | N | 10472954 | CYTARABINE INTRATHECAL |
| 10006858 | 10004713 | null | 62.8 | Palliative (P) | 2018-06-24 | 2018-06-24 | DA 3+8 | 99 | Y | 10472954 | MPV |
| 10006859 | 10004715 | 1.69 | 65.7 | Curative (C) | 2018-12-21 | 2018-12-23 | Methotrexate High Dose (3g/m2) | null | null | 10473522 | VINFLUNINE |
| 10006860 | 10004715 | 1.8 | 70.9 | Adjuvant (A) | null | 2015-08-28 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 10473522 | CAPECITABINE + CARBOPLATIN |